The US Food and Drug Administration has approved the first medication for a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH, the agency said Thursday. NASH ...
When doctors told Katrina Barry that she had a rare and serious condition called pulmonary arterial hypertension or PAH, they ...
The US Food and Drug Administration has approved a fusion protein made by Merck & Co. for a rare, life-threatening lung ...
The US Food and Drug Administration (FDA) has approved the biosimilar tocilizumab-aazg (Tyenne), Fresenius Kabi, the drug's manufacturer, announced today. This is the second tocilizumab biosimilar ...
Endorsed by former United States Surgeon General Dr. Jerome Adams, OPVEE is the first nalmefene nasal spray to be approved by the FDA. Adams says the spray could be more effective than Narcan in ...
FDA approves biomarker for Alzheimer’s disease Dara Farhadi April 3, 2014 ... Another biomarker, Amyvid, developed by Eli Lilly, became the first beta-amyloid marker to be approved by the FDA in ...
Adults with heart disease will now be able to get a Wegovy prescription to reduce their risk of a heart attack or stroke - even if they are not obese. The FDA approved the medication for adults ...
March 1 (Reuters) - The U.S. health regulator on Friday approved Johnson & Johnson's (JNJ.N), opens new tab therapy in combination with other chemotherapies for the first-line treatment of a type ...
March 8 (Reuters) - The U.S. Food and Drug Administration approved Novo Nordisk's (NOVOb.CO), opens new tab weight-loss drug Wegovy on Friday for lowering the risk of stroke and heart attack in ...
Wegovy pens are sorted at Novo Nordisk's facility in Hillerod, Denmark, on Friday. (Tom Little/Reuters) The U.S. Food and Drug Administration approved the weight-loss drug Wegovy as a treatment to ...
Mirum has also submitted an additional supplemental new drug application to introduce a higher concentration formulation of Livmarli. The analyst is surprised by the label's age restriction of ≥ ...
The FDA has cleared Dexcom’s Stelo Glucose Biosensor System for over-the-counter use by people aged 18 years and older. The system is the first continuous glucose monitor to be made available ...